World Asset Management’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-3,331
Closed -$200K 1123
2019
Q3
$200K Buy
+3,331
New +$198K 0.01% 1041
2019
Q2
Sell
-3,892
Closed -$217K 1200
2019
Q1
$217K Buy
+3,892
New +$198K 0.01% 1005
2018
Q4
Sell
-4,062
Closed -$268K 1146
2018
Q3
$268K Buy
4,062
+9
+0.2% +$559 0.01% 995
2018
Q2
$261K Buy
+4,053
New +$251K 0.01% 1030
2017
Q4
Sell
-4,226
Closed -$213K 1515
2017
Q3
$213K Buy
4,226
+222
+6% +$11.4K 0.01% 1352
2017
Q2
$218K Buy
+4,004
New +$191K 0.01% 1296

Other funds holding IART

World Asset Management's IART Position: Q4 2019 in Review

World Asset Management sold out of Integra LifeSciences (IART) in Q4 2019, closing a stake of 3,331 shares — an estimated $200K sold.

World Asset Management first reported a position in IART in Q2 2017 and held it in 6 quarters. The position peaked at $268K in Q3 2018. 279 funds tracked by Wall St. Rank hold IART as of Q4 2019.

  • World Asset Management reported no remaining Integra LifeSciences position as of Q4 2019 after selling out during the quarter.
  • World Asset Management sold 3,331 Integra LifeSciences shares in Q4 2019, an estimated $200K.
  • World Asset Management first reported a position in Integra LifeSciences in Q2 2017 and held it in 6 quarters.
  • World Asset Management's Integra LifeSciences position peaked at $268K in Q3 2018.
  • 279 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2019.

Based on World Asset Management's 13F filing for Q4 2019, filed 28 Jan 2020.